- Home
- MPW vs SWTX Comparison
MPW vs SWTX Comparison
Compare MPW & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPW
- SWTX
- Stock Information
- Founded
- MPW 2003
- SWTX 2017
- Country
- MPW United States
- SWTX United States
- Employees
- MPW N/A
- SWTX N/A
- Industry
- MPW Real Estate Investment Trusts
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- MPW Real Estate
- SWTX Health Care
- Exchange
- MPW Nasdaq
- SWTX Nasdaq
- Market Cap
- MPW 3.5B
- SWTX 3.0B
- IPO Year
- MPW 2005
- SWTX 2019
- Fundamental
- Price
- MPW $6.03
- SWTX $44.13
- Analyst Decision
- MPW Hold
- SWTX Strong Buy
- Analyst Count
- MPW 7
- SWTX 5
- Target Price
- MPW $5.64
- SWTX $72.40
- AVG Volume (30 Days)
- MPW 10.5M
- SWTX 1.9M
- Earning Date
- MPW 05-08-2025
- SWTX 05-01-2025
- Dividend Yield
- MPW 5.32%
- SWTX N/A
- EPS Growth
- MPW N/A
- SWTX N/A
- EPS
- MPW N/A
- SWTX N/A
- Revenue
- MPW $1,038,695,000.00
- SWTX $191,589,000.00
- Revenue This Year
- MPW N/A
- SWTX $85.98
- Revenue Next Year
- MPW $6.96
- SWTX $69.16
- P/E Ratio
- MPW N/A
- SWTX N/A
- Revenue Growth
- MPW 17.27
- SWTX 3417.33
- 52 Week Low
- MPW $3.51
- SWTX $28.21
- 52 Week High
- MPW $6.55
- SWTX $62.00
- Technical
- Relative Strength Index (RSI)
- MPW 59.87
- SWTX 37.32
- Support Level
- MPW $6.06
- SWTX $45.88
- Resistance Level
- MPW $6.28
- SWTX $51.43
- Average True Range (ATR)
- MPW 0.18
- SWTX 1.98
- MACD
- MPW -0.03
- SWTX -0.79
- Stochastic Oscillator
- MPW 41.67
- SWTX 4.28
About MPW Medical Properties Trust Inc. common stock
Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.